Walberg Pushes for Bipartisan Bill to Lower Prescription Drug Costs
Washington, D.C.—Congressman Tim Walberg (MI-07) today called for action on H.R. 19, the Lower Costs, More Cures Act, and urged Speaker Pelosi to stop politicizing the drug pricing debate with needlessly partisan legislation that has no chance of becoming law. The Lower Costs, More Cures Act, which is co-sponsored by Walberg, is a bipartisan alternative that can pass the Senate and be signed into law by President Trump. Click here to watch Walberg’s remarks on the House floor.
“We need to act urgently to address the high cost of prescription drugs. Hardworking Michigan families are simply paying too much,” said Walberg. “Our legislation has strong bipartisan support and will help make medications more affordable without hindering our ability to develop life-saving cures and treatments. If Speaker Pelosi is serious about getting something to the President’s desk, she should stop playing politics with people’s health care and we should pass the Lower Costs, More Cures Act immediately.”
About H.R. 19, the Lower Costs, More Cures Act:
- Encourages innovation of groundbreaking new cures, promotes more low-cost options for patients, and curbs how drug companies can game the system.
- Provides first-ever out-of-pocket cap for seniors in the Medicare Part D program.
- Caps the cost of insulin for seniors in the Medicare Part D program.
- Increases transparency and removes uncertainty at the pharmacy counter.
- Cuts the cost of drug administration, including cancer treatment, for Medicare beneficiaries by as much as half.
- Stops subsidizing other developed countries’ health care through stronger trade agreements.
- Includes policy that has bipartisan, bicameral support and could be signed into law today.